In what is one of the biggest investments in the pharma sector in India in recent years, American giant Eli Lilly and Company is injecting over $1 billion (approx Rs 8,900 crore) in setting up new contract manufacturing facilities in India over the next few years. This includes a new manufacturing and quality hub in … Read more
Generic drugmaker Natco Pharma is considering spinning off its agro business, a move for which it got an in-principle approval from the board on Thursday. The board of directors has given in-principle approval to evaluate the demerger of the agro business of the into a separate entity. The management is of the opinion that the … Read more
US President Donald Trump on Friday announced a 100% tariff on pharma products, along with 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks starting on October 1.The announcements came in a series of posts on his social media platform indicating that he remains committed to tariffs beyond … Read more
Enzeme Biosciences is a biotech subsidiary of Alkem. It has announced a new manufacturing facility in the US with an investment of $70 million. The decision also aligns with President Trump’s call asking pharma companies to boost local manufacturing and generating employment. At present, Enzene has hired 50 people and aims to take a total … Read more
It was known that Boob family is expected to sell 24% stake of the Company. In the last conference call this was discussed and management (Sikchi family) had informed that it was due to Boob family’s estate planning and not any operational concerns. Sikchi family had also committed that they are not looking to sell … Read more
Alkem was speculated to be the front runner to acquire JB Chem & Pharmaceuticals (JB) from KKR. Torrent had previously dropped out due to the valuation differences. However, finally it’s Torrent who acquires JB. Torrent will acquire 46.39% stake from promoters Tau Investment Holdings Pte Ltd (a unit of KKR) for Rs 11,917 crore; a … Read more
Private equity firm Advent International has signed a definitive agreement to invest $175 million (about ₹1,500 crore) for a significant minority stake in Felix Pharmaceuticals Pvt. Ltd, an Ireland-headquartered company focused on developing and manufacturing generic medicines for companion animals such as dogs, cats, and horses. This marks another bet by Advent in the growing … Read more
The initiative, part of the Promotion of Research & Innovation in Pharma MedTech Sector (PRIP) scheme—launched in August 2023 for a five-year period—seeks to boost domestic R&D and reduce India’s reliance on imported technology. Also read: DCGI seeks post-market surveillance data on 2 combination drugs within 3 months “We are planning to float the expression … Read more
Medicamen has recently won a new long term contract manufacturing contract from a US distributor. Company has now announced a board meeting on February 26, 2025 to consider a new fund raise. The intention is to raise some sort of equity (direct or convertible) by way of Preferential Issue/ Rights Issue/ QIP/ or any other … Read more